Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Balance Sheet Related Disclosures [Abstract] | ||
| Accrued research and development | $ 1,257 | $ 1,043 |
| Accrued compensation | 1,241 | 1,642 |
| Accrued restructuring charges | 28 | 744 |
| Accrued other | 563 | 288 |
| Total | $ 3,089 | $ 3,717 |
| X | ||||||||||
- Definition Accrued expenses and other current liabilities. No definition available.
|
| X | ||||||||||
- Definition Accrued research and development, current. No definition available.
|
| X | ||||||||||
- Definition Accrued restructuring charges. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|